Quick answers
- Is CVE-2026-108920 exploited in the wild?
- No. Junglewise Threat Intelligence has no report of CVE-2026-108920 being exploited in the wild.
- How severe is CVE-2026-108920?
- Medium severity, with a CVSS score of 4.3, published 12 October 2026.
- Which products and versions are affected?
- SourceCodester Drug Recommendation System 1.0.
- Is there a fix for CVE-2026-108920?
- No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
- How is CVE-2026-108920 attacked?
- It is attacked over the network.
- Am I affected by CVE-2026-108920?
- Check whether you run SourceCodester Drug Recommendation System at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.
Technical details
A cross-site scripting (XSS) vulnerability exists in the Admin/user_record.php file's Admin Record Tables component. The vulnerability arises from insufficient sanitization of the name and email parameters, allowing an attacker to inject arbitrary JavaScript code that executes in the context of an admin's session without authentication required beyond network access. This is a reflected or stored XSS that could be exploited to steal administrative credentials or perform unauthorized actions.
Affected products
- SourceCodester Drug Recommendation System 1.0
Timeline
- 2026-10-12: disclosed
- 2026-10-12: advisory